Trial Profile
A Study of the Pharmacokinetics of Dexmedetomidine in Morbid Obesity
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium; Pain
- Focus Pharmacokinetics
- 11 Mar 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Jun 2014 to 1 Jun 2015.
- 11 Mar 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Jun 2014 to 1 Jun 2015.
- 12 Dec 2013 Planned number of patients changed from 35 to 20 as reported by ClinicalTrials.gov.